EMA Authorised: Liraglutide STADA (liraglutide) — STADA Arzneimittel AG

View source ↗

Summary

The EMA authorises Liraglutide STADA (liraglutide) for diabetes mellitus, with STADA Arzneimittel AG as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Liraglutide STADA (liraglutide)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: STADA Arzneimittel AG. Decision date: 15/07/2026